Ye Edward Tian
Technik-/Wissenschafts-/F&E-Leiter bei IMPACT Therapeutics, Inc.
Ursprung des Netzwerks ersten Grades von Ye Edward Tian
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
IMPACT Therapeutics, Inc.
 IMPACT Therapeutics, Inc. Pharmaceuticals: GenericHealth Technology IMPACT Therapeutics, Inc. manufactures pharmaceutical products. The firm develops discovery and commercialization of novel therapeutics to treat cancer and other life-threatening diseases. The company was founded in 2009 and is headquartered in Nanjing, China.
1
| Holding Company | Pharmaceuticals: Generic | 1 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Ye Edward Tian
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
BiTech Pharma, Inc.
 BiTech Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services BiTech Pharma, Inc. develops medicines. The private company is based in Emeryville, CA. Xiang Wu Ye has been the CEO of the company since 2008. | Miscellaneous Commercial Services | Chairman | |
Beijing Shenogen Pharma Group Ltd.
 Beijing Shenogen Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Beijing Shenogen Pharma Group Co. Ltd. engages in the manufacture of icaritin drug products. It focuses on the treatment of multiple malignant tumors such as hepatocellular carcinoma, breast cancer, non-small cell lung cancer, and lymphoma. The company was founded by Kun Meng and Zhao Yi Wang on May 5, 2008 and is headquartered in Beijing, China. | Pharmaceuticals: Major | Director/Board Member | |
| TRANSCENTA HOLDING LIMITED | Pharmaceuticals: Major | Director/Board Member | |
ICOS Corp.
 ICOS Corp. Pharmaceuticals: OtherHealth Technology ICOS Corp. manufactures medications to treat inflammation and other serious diseases. It focuses on the development of treatments for unmet medical conditions such as prostatic hyperplasia, hypertension, pulmonary arterial hypertension, cancer, and inflammatory diseases. The company was founded in 1989 by Christopher Henney and George Rathman and is headquartered in Bothell, WA. | Pharmaceuticals: Other | Corporate Officer/Principal | |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| CTI BIOPHARMA CORP. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Shandong University | College/University | Undergraduate Degree | |
| University of Kansas | College/University | Doctorate Degree | |
| The University of Chicago | College/University | Masters Business Admin | |
| Glaxosmithkline China Ltd. | Corporate Officer/Principal | ||
| PROCTER & GAMBLE COMPANY | Household/Personal Care | Corporate Officer/Principal |
Statistik
International
| Vereinigte Staaten | 8 |
| China | 4 |
| Cayman Islands | 2 |
Sektoral
| Health Technology | 6 |
| Consumer Services | 4 |
| Commercial Services | 2 |
| Consumer Non-Durables | 2 |
Operativ
| Corporate Officer/Principal | 6 |
| Director/Board Member | 2 |
| Chairman | 1 |
| Independent Dir/Board Member | 1 |
| Chief Executive Officer | 1 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Jun Bao | 12 |
- Börse
- Insiders
- Ye Edward Tian
- Unternehmensverbindungen
